Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Teva Pharmaceutical Industries Ltd. (NYSE: TEVA).

Full DD Report for TEVA

You must become a subscriber to view this report.


Recent News from (NYSE: TEVA)

Teva down 3% premarket on expanded investigation into generic drug price fixing
Teva Pharmaceutical Industries (NYSE: TEVA ) is down  3%  premarket on light volume on the heels of a Washington Post article about an ongoing lawsuit claiming illegal price fixing among generic drug firms that now includes 47 U.S. states. More news on: Teva Pharmaceutical Indu...
Source: SeekingAlpha
Date: December, 10 2018 07:57
Berkshire Hathaway: Are Warren Buffett & Co. Losing Their Midas Touch?
Introduction Last week, we had an interesting discussion on our chat room regarding the high level of cash, about $103.64B (or 34.6% of the liquid-invested portfolio), that Berkshire Hathaway ( BRK.A )( BRK.B ) maintain on its balance sheet. It started with a question by one of our subsc...
Source: SeekingAlpha
Date: December, 10 2018 07:37
5%+ Dividend Yield Portfolio: Profiting From A Return To Normal (October 2018 Review)
Outlook Volatility has returned to the markets. By this I don’t mean the big dig from the recent price highs... I am referring to the "normal" week-to-week and month-to-month gyrations that have are closer to the historical trends than the quiet uptrend that has mostly defined the...
Source: SeekingAlpha
Date: December, 03 2018 23:14
Biohaven Pharma up 17% on positive data on migraine med Zydis
Thinly traded Biohaven Pharmaceutical Holding Company ( BHVN +17.1% ) is up on more than double normal volume following its announcement of topline data from a Phase 3 clinical trial, BHV3000-303 , evaluating lead candidate Zydis (rimegepant) orally dissolving tablet for the acute treat...
Source: SeekingAlpha
Date: December, 03 2018 12:05
Detailed Research: Economic Perspectives on American Tower Corporation (REIT), Ligand Pharmaceuticals, Teva Pharmaceutical Industries, Cummins, Alexander's, and Korea Electric Power - What Drives Growth in Today's Competitive Landscape
NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of American Tower Corporation (REIT) (NYSE:AMT), Ligand Pharmaceuticals I...
Source: GlobeNewswire
Date: November, 29 2018 08:50
Tech Slump Submerges Stocks In Red Sea (Wall Street Breakfast Podcast)
Today's top stories: Tech slump submerges stocks in Red Sea; record breaking number of Americans expected to travel this Thanksgiving; and Bitcoin tumbles 20 percent overnight. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following ...
Source: SeekingAlpha
Date: November, 20 2018 07:33
Wall Street Breakfast: Tech Slump Submerges Stocks In Red Sea
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes , Stitcher and SoundCloud (click the highlighted links). Stocks across the globe slid overnight, extending the latest wave of selling amid pressure on the technology secto...
Source: SeekingAlpha
Date: November, 20 2018 07:00
Opioid industry fights New York Stewardship Act
Opioid makers and distributors are fighting New York's Opioid Stewardship Act, which aims to collect $600M from the industry over six years to help defray costs of the opioid crisis. More news on: CVS Health Corporation, Endo International plc, Teva Pharmaceutical Industries Limited, Hea...
Source: SeekingAlpha
Date: November, 20 2018 03:02
Why We Pass On Amgen
Amgen's stock is the leading iShares Nasdaq Biotechnology ETF ( IBB ) component. However, we don't think that its stock is going to grow faster than other stocks represented in IBB. While other major biotech companies have suffered stock declines due to weakened sales forecast, Amgen has not...
Source: SeekingAlpha
Date: November, 06 2018 11:53
Monday's Top Healthcare Stocks To Watch Ahead Of Elections
CORAL GABLES, FL / ACCESSWIRE / November 5, 2018 / It's no secret that technology has facilitated access and directly helped meet consumer needs in a multitude of industries. Healthcare has become the latest market to take full advantage of this trend. With the advent of technology in he...
Source: ACCESSWIRE IA
Date: November, 05 2018 11:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1422.4422.2122.5722.1810,367,687
2018-09-0721.3021.5021.8021.029,692,296
2018-09-0622.6021.7522.66521.5516,139,722
2018-09-0522.5822.6422.9222.456,848,178
2018-09-0422.7222.7022.8922.358,611,450

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10937,9601,666,25356.2916Short
2018-12-07485,159784,18361.8681Short
2018-12-06609,6751,029,77159.2049Short
2018-12-04292,536897,70332.5872Cover
2018-12-03157,877329,55747.9058Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TEVA.


About Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)

Logo for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)

Not available

 

Contact Information

 

 

Current Management

  • Israel Makov / President, CEO
  • Dan Suesskind / CFO

Current Share Structure

     


    Recent Filings from (NYSE: TEVA)

    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: August, 02 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: August, 02 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: June, 06 2018
    Specialized Disclosure Report
    Filing Type: SDFiling Source: edgar
    Filing Date: May, 31 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 03 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 03 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 27 2018
    Official notification to shareholders of matters to be brought to a vote (Proxy)
    Filing Type: DEF 14AFiling Source: edgar
    Filing Date: April, 25 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: April, 25 2018
    Prospectus filed under Rule 424(b)(3)
    Filing Type: 424B3Filing Source: edgar
    Filing Date: April, 19 2018

     

     


    Daily Technical Chart for (NYSE: TEVA)

    Daily Technical Chart for (NYSE: TEVA)


    Stay tuned for daily updates and more on (NYSE: TEVA)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NYSE: TEVA)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TEVA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TEVA and does not buy, sell, or trade any shares of TEVA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/